No abstract available.
Adult ; Biopsy ; Brain/*pathology ; Brain Neoplasms/*pathology ; Contrast Media/diagnostic use ; Diagnosis, Differential ; Gadolinium DTPA/diagnostic use ; *HIV Seropositivity ; Humans ; Image Enhancement/methods ; Immunocompetence ; Lymphoma, Non-Hodgkin/*pathology ; Magnetic Resonance Imaging/*methods ; Male ; Sensitivity and Specificity

PURPOSE: To evaluate the outcome of visual internal urethrotomy with a holmium:yttrium-aluminum-garnet laser along with intralesional triamcinolone injection. MATERIALS AND METHODS: Patients with an anterior urethral stricture less than 3 cm in length were evaluated by clinical history, physical examination, uroflowmetry, and retrograde urethrogram preoperatively. All patients were treated with holmium laser urethrotomy and intralesional triamcinolone (80 mg) injection under general or regional anesthesia. An 18 F urethral catheter was placed for 5 days. All patients were followed up for 12 months postoperatively by history, uroflowmetry, and if required, retrograde urethrogram or urethroscopy every 3 months. RESULTS: The mean age of the patients was 42.9 years (range, 14 to 70 years). The overall recurrence rate was 24%. The success rate in patients with strictures less than 1 cm in length was 95.8%, whereas that in patients with strictures of 1 to 3 cm in length was 57.7% (p=0.002). The outcome did not depend on age, duration of symptoms, etiology, or location of stricture. CONCLUSIONS: Holmium laser urethrotomy with intralesional triamcinolone is a safe and effective minimally invasive therapeutic modality for urethral strictures. This procedure has an encouraging success rate, especially in those with stricture segments of less than 1 cm in length.
Anesthesia, Conduction ; Constriction, Pathologic ; Holmium ; Humans ; Laser Therapy ; Lasers, Solid-State ; Physical Examination ; Recurrence ; Triamcinolone ; Triamcinolone Acetonide ; Urethral Stricture ; Urinary Catheters